Esophageal Cancer Clinical Trial
Official title:
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
This clinical trial is designed to be a multi-center prospective observational study which shall compare the effect of different postoperative home nutrition modes on recent nutritional index (weight/BMI) of patients with esophageal cancer and recent outcomes. Different postoperative home nutrition modes adopted in this study includes oral natural diet, oral nutrition supplement and tube feeding.
STUDY BACKGROUND Esophageal cancer is a common cancer in China and due to its influence on
diet intake, patients with esophageal cancer are often combined with nutrition deficiency,
which causes relatively high nutrition risk to treatment. Studies conducted by Martin et al
showed that the degree of body weight loss in patients with malignancy is related to BMI
level and prognosis. The patients with severe body weight loss and low BMI have poor
prognosis, especially for patients with esophageal cancer.
At present, perioperative nutrition support for patients with esophageal cancer has been
recognized and has been recommended as routine in 2017 NCCN guideline. How to implement good
home nutrition within one month after patient discharge and recover nutrition index as soon
as possible has become a focus for esophageal surgeon.
Many clinical trials have already investigated enteral nutrition support approach during
anti-cancer treatment period in patients with malignancy. However, only a few clinical trials
are good designed. Therefore the investigators hope to via this multi-center prospective
observational study to provide evidence for this question.
OBJECTIVES:
1. To explore the relationship between postoperative home nutrition support treatment
approach and nutritional status of patients with esophageal cancer;
2. To explore the relationship between postoperative home nutrition support treatment
approach and recent prognosis in patients with esophageal cancer;
3. To promote the standardized application of postoperative home nutrition support
treatment for patients with esophageal cancer.\
OUTLINE:
Included patients shall be divided into three groups according to the treatment plan of all
centers, including oral natural diet, oral nutrition supplement and tube feeding. As for
patients in oral natural diet group, the patients shall receive oral natural diet. As for
patients in oral nutrition supplement group, in addition to oral natural die, the
participants shall receive oral enteral supplement providing 750-1500kcal/d. As for patients
in tube feeding group, in addition to oral natural die, the participants shall receive tube
feeding enteral supplement providing 750-1500kcal/d.
All the included patients shall be followed up weekly within 1-3 weeks after discharge via
telephone, at Day 30 after discharge and at Day 90 after discharge to assess the
effectiveness and safety of different home nutrition supplement approaches.
PROJECTED ACCRUAL: A total of 600 patients will be accrued for this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|
||
Not yet recruiting |
NCT05542680 -
Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal Cancer
|
N/A | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Completed |
NCT00003864 -
Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
|
Phase 2 | |
Recruiting |
NCT05491616 -
Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study
|
Phase 2 | |
Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT00199849 -
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
|
Phase 1 | |
Completed |
NCT03756597 -
PAN-study: Pan-Cancer Early Detection Study (PAN)
|
||
Completed |
NCT00400114 -
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
|
Phase 2 | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Recruiting |
NCT04615806 -
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy
|
N/A | |
Active, not recruiting |
NCT04566367 -
Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer
|
N/A | |
Active, not recruiting |
NCT03962179 -
Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)
|
N/A | |
Terminated |
NCT01446874 -
Prevention of Post-operative Pneumonia (POPP)
|
Phase 2/Phase 3 | |
Completed |
NCT03468634 -
Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy
|
N/A | |
Active, not recruiting |
NCT02869217 -
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
|
Phase 1 | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Recruiting |
NCT02544737 -
Apatinib for Metastatic Esophageal Cancer.
|
Phase 2 |